Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.

Neurology and therapy·2026
Same author

Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study.

The journal of headache and pain·2026
Same author

Incisional Hernia Repair: Meta-Analysis on Laparoscopic and Open Surgical Repair.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2025
Same author

A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II).

Journal of neurology·2025
Same author

Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations.

Diagnostics (Basel, Switzerland)·2024
Same author

Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature.

Journal of surgical case reports·2024

Related Experiment Video

Updated: Apr 27, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

1.1K

Laparoscopic splenectomy coupled with laparoscopic cholecystectomy.

Rosario Vecchio1, Eva Intagliata2, Salvatore Marchese1

  • 1Department of Surgery, University of Catania, Italy.

JSLS : Journal of the Society of Laparoendoscopic Surgeons
|June 25, 2014
PubMed
Summary

Laparoscopic splenectomy and cholecystectomy is a safe and feasible procedure for patients with concurrent spleen and gallbladder diseases. This minimally invasive approach offers good outcomes when performed by experienced surgical teams.

More Related Videos

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
04:03

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery

Published on: March 28, 2025

692
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

998

Related Experiment Videos

Last Updated: Apr 27, 2026

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

1.1K
Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
04:03

Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery

Published on: March 28, 2025

692
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

998

Area of Science:

  • Minimally invasive surgery
  • Gastrointestinal surgery
  • Hepatobiliary surgery

Background:

  • Coexisting spleen and gallbladder diseases require careful surgical consideration.
  • Laparoscopic approaches are increasingly preferred for abdominal procedures.
  • Evaluating combined laparoscopic splenectomy and cholecystectomy is crucial.

Purpose of the Study:

  • To assess the outcomes of laparoscopic surgery for patients with both spleen and gallbladder conditions.
  • To determine the safety and feasibility of concomitant laparoscopic splenectomy and cholecystectomy.

Main Methods:

  • A retrospective review of 12 patients who underwent simultaneous laparoscopic splenectomy and cholecystectomy between May 2004 and October 2012.
  • Indications included idiopathic thrombocytopenic purpura, hereditary spherocytosis, and thalassemia intermedia.
  • Surgical outcomes, operative time, blood loss, and complications were analyzed.

Main Results:

  • The mean operative time was 100 minutes with minimal blood loss (mean 50 mL).
  • One conversion to open surgery was necessary; no major complications or deaths occurred.
  • The average hospital stay was 5 days.

Conclusions:

  • Concomitant laparoscopic splenectomy and cholecystectomy is a safe and feasible surgical option.
  • This procedure can be effectively performed for combined spleen and gallbladder pathologies.
  • Experienced surgical teams are essential for successful outcomes.